Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Volasertib and Romidepsin in R/R PTCL and CTCL
NCT02757248Phase 1Withdrawn
- Start
- Nov 2016
- Primary completion
- Nov 2016
01
Overview
Phase 1, open-label trial of volasertib in peripheral T-cell lymphoma (PTCL) and cutaneous T-cell lymphoma (CTCL). Planned start Nov 2016; status: withdrawn.
02
Drugs
volasertib
03
Conditions
peripheral T-cell lymphoma (PTCL)cutaneous T-cell lymphoma (CTCL)
Beyond the preview
Go deeper on NCT02757248.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02757248.